These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3957657)

  • 1. Emergency treatment of intractable migraine.
    Gallagher RM
    Headache; 1986 Feb; 26(2):74-5. PubMed ID: 3957657
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: evaluations by patients.
    Davis CP; Torre PR; Williams C; Gray C; Barrett K; Krucke G; Peake D; Bass B
    Am J Emerg Med; 1995 Mar; 13(2):146-50. PubMed ID: 7893296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine.
    Scherl ER; Wilson JF
    Headache; 1995 May; 35(5):256-9. PubMed ID: 7775186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.
    Carleton SC; Shesser RF; Pietrzak MP; Chudnofsky CR; Starkman S; Morris DL; Johnson G; Rhee KJ; Barton CW; Chelly JE; Rosenberg J; Van Valen MK
    Ann Emerg Med; 1998 Aug; 32(2):129-38. PubMed ID: 9701293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient home-based continuous intravenous dihydroergotamine therapy for intractable migraine.
    Charles JA; von Dohln P
    Headache; 2010 May; 50(5):852-60. PubMed ID: 20132337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous dihydroergotamine for inpatient management of refractory primary headaches.
    Nagy AJ; Gandhi S; Bhola R; Goadsby PJ
    Neurology; 2011 Nov; 77(20):1827-32. PubMed ID: 22049203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for the emergency treatment of migraine headache.
    Lobo BL; Landy S
    J Tenn Med Assoc; 1994 Feb; 87(2):53-4. PubMed ID: 8176912
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations of the "carry-over effect" following successful termination of chronic migraine in the adolescent with short-term dihydroergotamine, dexamethasone and hydroxyzine: a pilot study.
    Charles JA; Jotkowitz S
    J Headache Pain; 2005 Feb; 6(1):51-4. PubMed ID: 16362192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature.
    Colman I; Brown MD; Innes GD; Grafstein E; Roberts TE; Rowe BH
    Ann Emerg Med; 2005 Apr; 45(4):393-401. PubMed ID: 15795718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache.
    Belgrade MJ; Ling LJ; Schleevogt MB; Ettinger MG; Ruiz E
    Neurology; 1989 Apr; 39(4):590-2. PubMed ID: 2648190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive intravenous dihydroergotamine as therapy for intractable migraine.
    Raskin NH
    Neurology; 1986 Jul; 36(7):995-7. PubMed ID: 3520384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of transformed refractory migraine with intravenous dihydroergotamine].
    Cid C; Ortega-Valín F; Valero M; Muñoz R; Pascual J
    Neurologia; 1999; 14(6):315-8. PubMed ID: 10439626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroergotamine: a review of its use in the treatment of migraine and other headaches.
    Scott AK
    Clin Neuropharmacol; 1992 Aug; 15(4):289-96. PubMed ID: 1516074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative Effectiveness of Dopamine Antagonists for Pediatric Migraine in the Emergency Department.
    Sheridan DC; Laurie A; Pacheco S; Fu R; Hansen ML; Ma OJ; Meckler GD
    Pediatr Emerg Care; 2018 Mar; 34(3):165-168. PubMed ID: 27176905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-refractory migraine: the case for opioid therapy.
    Rothrock JF
    Headache; 2008 Jun; 48(6):850-4. PubMed ID: 18549362
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of intravenous valproate sodium in status migraine.
    Norton J
    Headache; 2000 Oct; 40(9):755-7. PubMed ID: 11091297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IV dihydroergotamine therapy for migraine treatment.
    Stein M
    Ann Emerg Med; 1988 Jul; 17(7):764. PubMed ID: 3382085
    [No Abstract]   [Full Text] [Related]  

  • 18. Methadone: an effective agent in managing intractable pain as a symptom of psychotic anger.
    Berken GH; Stone MM; Stone SK
    Ann N Y Acad Sci; 1982; 398():83-6. PubMed ID: 6961871
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Hoernecke R; Doenicke A
    Med Klin (Munich); 1993 Nov; 88(11):642-8. PubMed ID: 8295604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in migraine: treatment with dihydroergotamine-retard.
    Mastrosimone F; Iaccarino C
    Cephalalgia; 1983 Aug; 3 Suppl 1():168-70. PubMed ID: 6616599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.